The global Digital Pathology Market is estimated to be valued at US$ 884.4 Million in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Digital pathology is the use of digital scanning devices to convert glass slides into full resolution digital slides that can be viewed, managed, shared and analyzed on a computer monitor. Digital pathology solutions offer benefits such as remote diagnosis, multi-user access and integration with various laboratory systems and electronic health records.
Market key trends:
AI and machine learning are being integrated with digital pathology solutions to assist pathologists in diagnosis. AI helps in automating processes such as slide scanning, data extraction from slides and analyzing large volumes of molecular data. It aids in detecting cancers, assessing prognosis and predicting treatment response. AI algorithms are being trained on large datasets to recognize patterns and make accurate diagnosis. This reduces diagnostic errors and variation while improving efficiency.
Segment Analysis
The Global Digital Pathology Market Size is segmented by type into hardware, software, and storage. The hardware segment dominated the market in 2021 and is expected to remain the largest segment during the forecast period. Advances in digital pathology scanners and increasing adoption of whole slide imaging systems by diagnostic laboratories are driving the hardware segment.
Key Takeaways
Market size: The global digital pathology market is expected to witness high growth, exhibiting a CAGR of 12% over the forecast period, due to increasing demand for efficient diagnostic solutions and rising applications of digital pathology in drug development and companion diagnostics.
Regional analysis: North America dominated the global market in 2021 due to rapid adoption of digital pathology systems and presence of major market players in the US. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to rising healthcare expenditure, increasing cancer cases, and developing healthcare infrastructure in the region.
Key players: Key players operating in the digital pathology market are Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc., Nucleai, Inc. Leica Biosystems is one of the leading players dominating the market owing to its well-established brand and wide array of digital pathology solutions.
For More Insights, Read- https://www.newsstatix.com/digital-pathology-market-size-share-analysis-2023-2030/
Comments
0 comment